In this article, we will look at the 10 Best Growth Stocks With Highest Upside Potential.
Growth stocks with large implied upside are getting another look as investors try to separate real earnings momentum from stocks that simply look cheap against analyst target prices.
BlackRock says “Earnings strength is broadening” and points to a “new trend of upward revisions,” while also noting that “non-Mag 7 earnings power may be underappreciated.” In summary, the growth story is no longer only about the largest technology names, which gives investors more room to look for stocks where analyst expectations have not fully caught up. Fidelity says “Tech is still king” and remains “ground zero for earnings growth,” with “technology remains difficult to replace” for investors looking for durable expansion. AllianceBernstein adds that growth stocks still have “long-term growth potential,” supported by “strong earnings and continued AI-related capital spending” and broader “structural growth drivers.”
Against this backdrop, growth stocks with the highest upside potential deserve a closer look. The more interesting names are those where revenue growth, earnings revisions, sector demand, and analyst sentiment are moving in the same direction. With that in mind, let’s take a look at the 10 Best Growth Stocks With Highest Upside Potential.
Our Methodology
We used the Finviz screener to identify stocks that have posted compounded annual revenue growth of over 30% in the past 3 years and whose median analyst price target offers at least 40% upside. We then limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
10. Coinbase Global, Inc. (NASDAQ:COIN)
On July 10, 2026, Coinbase Global, Inc. (NASDAQ:COIN) announced that Paul Grewal had notified the company of his intention to step down as Chief Legal Officer and Secretary, effective July 31. In connection with the resignation, Coinbase expects to appoint Molly Abraham, Vice President, Legal, as General Counsel and Secretary. On July 8, Coinbase and Grewal entered into an advisor agreement under which Grewal will assist with the transition and provide other advisory services from August 1 to October 31. Grewal will receive a lump sum payment equal to three months of current base salary after the advisory period and continued vesting of restricted stock units scheduled to vest on August 20, subject to continued service under the agreement.
On July 9, Citizens analyst Devin Ryan lowered the firm’s price target on Coinbase to $325 from $355 and kept an Outperform rating on the shares.
On July 7, US Tiger upgraded Coinbase to Buy from Hold with a $200 price target, citing a “more constructive view” on Bitcoin’s cycle risk/reward. US Tiger said the largest part of cycle de-risking is already behind us after a roughly 54% drawdown from the October 2025 cycle high, reset on-chain profitability, and roughly three realized-loss capitulation waves.
Coinbase Global, Inc. (NASDAQ:COIN) operates a platform for crypto assets in the United States and internationally.
9. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
On July 10, 2026, Morgan Stanley raised the firm’s price target on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) to $400 from $370 and kept an Equal Weight rating on the shares.
On July 9, Raymond James raised the firm’s price target on Alnylam to $468 from $420 and kept an Outperform rating on the shares. Raymond James said Ionis’ (IONS) failed Phase 3 ATTR-CM trial strengthens Alnylam’s competitive position by reducing a key rival to its TTR silencer franchise and improving the outlook for pricing. The firm also noted that the results may raise some risk for Alnylam’s next-generation nucresiran trial in patients receiving background tafamidis.
On June 29, H.C. Wainwright lowered the firm’s price target on Alnylam to $470 from $510 and kept a Buy rating on the shares. H.C. Wainwright reduced near-term estimates for Amvuttra but continued to estimate Alnylam’s TTR franchise growing to over $20B in annual revenues by 2040.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
8. Pan American Silver Corp. (NYSE:PAAS)
On July 6, 2026, Jefferies lowered the firm’s price target on Pan American Silver Corp. (NYSE:PAAS) to $53 from $54 previously and kept a Buy rating on the shares. Jefferies said gold has declined from about $4,700/oz to roughly $4,200/oz since Q1, setting up Q2 as a period of likely margin contraction driven by lower gold prices and elevated diesel costs.
On July 9, BofA lowered the firm’s price target on Pan American Silver Corp. (NYSE:PAAS) to $69 from $77 previously and kept a Buy rating on the shares. BofA said reductions in commodity price forecasts, particularly for precious and base metals, have led to lower sector estimates and valuations. The firm expects challenging market conditions through autumn before a potential recovery.
Pan American Silver Corp. (NYSE:PAAS) engages in the exploration, mine development, extraction, processing, refining, and reclamation of mines in Chile, Peru, Brazil, Mexico, Canada, Argentina, Bolivia, and Guatemala.
7. Circle Internet Group (NYSE:CRCL)
On July 10, 2026, Clear Street analyst Owen Lau noted that Circle Internet Group (NYSE:CRCL) received final approval from the U.S. Office of the Comptroller of the Currency to establish a national trust bank that will operate as Circle National Trust. Lau said the approval follows conditional approval in December 2025 and places Circle National Trust under direct federal oversight by the OCC.
Clear Street said the license offers at least three new functions for Circle, including federally regulated fiduciary digital-asset custody, direct institutional custody, and USDC Reserve management. Lau called the approval another milestone for Circle and the industry in offering traditional services previously reserved for large banks. While the immediate revenue contribution is minimal, Clear Street said the stock was up about 7% in midday trading, reflecting a prior overshoot to the downside due to OUSD competition and the potential to capture a new revenue stream longer term. Clear Street has a Buy rating and a $157 price target on the shares.
Also on July 10, Circle Internet Group announced that it received OCC approval to establish First National Digital Currency Bank, N.A., a national trust bank that will operate under the name Circle National Trust. The company said the bank will offer fiduciary digital asset custody services for Circle and its affiliates upon opening and may eventually offer digital asset custody services to a limited number of institutional customers. On July 8, US Tiger analyst Bo Pei upgraded Circle Internet to Buy from Hold with a $100 price target, saying stablecoin competition concerns have been “over-discounted.”
Circle Internet Group (NYSE:CRCL) operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.
6. Palantir Technologies Inc. (NASDAQ:PLTR)
On July 9, 2026, Rackspace (RXT) and Palantir Technologies Inc. (NASDAQ:PLTR) announced an operating model framework to help regulated and sovereign enterprises own and operate AI in production. Delivered through Rackspace, the framework combines Palantir Foundry and AIP with Rackspace’s governed private cloud, sovereign cloud, on-prem infrastructure, certified FDEs, and managed operations for customers that require control over data, security, governance, deployment location, and operational outcomes.
Rackspace said the framework is built for markets such as healthcare, financial institutions, energy operators, and sovereign organizations that cannot move data across borders. Rackspace has scaled to approximately 400 Palantir certifications across sales, engineering, delivery, and operations, including a global cohort of Palantir-certified forward-deployed engineers. Rackspace is also committing to deploy Foundry and AIP across more than 70% of its own back-office operations under the Rackspace OneOS program.
On July 8, SNP SE and Palantir announced a strategic partnership at SNP’s Transformation World event in Heidelberg, Germany. The first joint solution, Test Data Proposal, automates the identification of relevant test data for customer test cases and will expand SNP’s Kyano platform.
On July 7, Palantir announced an enterprise expansion agreement with GNP Seguros, its first publicly announced commercial customer in Latin America. GNP Seguros has used Palantir’s Foundry and Artificial Intelligence Platform to detect claims fraud, monitor risk, and improve underwriting.
Palantir Technologies Inc. (NASDAQ:PLTR) builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.
While we acknowledge the potential of PLTR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PLTR and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see the 5 Best Growth Stocks With Highest Upside Potential.
Disclosure: None. Follow Insider Monkey on Google News.
